TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells

Medicine and Dentistry

• Acute Myeloid Leukemia 100%
• Stem Cell 87%
• Combination Therapy 50%
• T Cell 50%
• Immunoglobulin 50%
• Mucin 3 50%
• Hematopoietic Stem Cell 25%
• Cytotoxicity 12%
• Hematopoiesis 12%
• Membrane Antigen 12%
• Acute Promyelocytic Leukemia 12%
• Xenograft 12%
• Immunoglobulin G2a Antibody 12%

Biochemistry, Genetics and Molecular Biology

• Stem Cell 87%
• Immunoglobulin 50%
• T Cell 50%
• Mucin 50%
• Hematopoietic Stem Cell 25%
• Surface Property 12%
• Mouse 12%
• Human 12%
• Molecule 12%
• Antibody 12%
• Self Concept 12%
• Cytotoxicity 12%
• Normal Human 12%
• Hematopoiesis 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Myeloid Leukemia 100%
• Immunoglobulin 50%
• Mucin 3 50%
• Human 12%
• Mouse 12%
• Normal Human 12%
• Promyelocytic Leukemia 12%
• Membrane Antigen 12%
• Immunoglobulin G2a Antibody 12%